NRF2 activators inhibit influenza A virus replication by interfering with nucleo-cytoplasmic export of viral RNPs in an NRF2-independent manner
Table 2
Covalent binding energies of the compounds to the BTB domain of human KEAP1.
Covalent binding energies of the compounds to the BTB domain of human KEAP1.